论文部分内容阅读
Immune checkpoint blockade therapy,which targets T cells to enhance the antitumor immune response,has become a promising treatment for many cancer types1,2.Till now,a total of 6 checkpoint inhibitors targeting cytotoxic T lymphocyte antigen-4(CTLA-4)。